BMA wants licensing of cannabis to be changedBMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7119.1327c (Published 22 November 1997) Cite this as: BMJ 1997;315:1327
- Susan Mayor
The BMA has called for a change in the licensing of certain cannabinoids to enable properly controlled trials of these agents in a range of conditions.
Earlier this year the association's annual representative meeting resolved that certain cannabinoids should be legalised for wider medicinal use. The report Therapeutic Uses of Cannabis develops this policy by describing the scientific evidence for wider medicinal use of cannabinoids—a family of compounds which constitute the active ingredients of cannabis—and defining future research needs.
The report points out that accumulation of scientific evidence on …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial